Sze-Wai Chan

2PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 12, 2024
Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.

Graham Cohen, Bernardo Rapoport, Sze W Chan

|Aug 11, 2020
Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer.

Bernardo L Rapoport, Annette J Theron, Daniel A Vorobiof

Pageof 1

Frequent Collaborators

2 joint publications

Bernardo Rapoport

1 joint publications

Graham Cohen

1 joint publications

Annette J Theron

1 joint publications

Daniel A Vorobiof